Sesen Bio (SESN) News Today → Investors Alert: The Next Big Thing in Weight Loss (From Behind the Markets) (Ad) Free SESN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTrey Mewesstartribune.com - April 10 at 12:53 AMSesen Bio (NASDAQ: SESN)fool.com - August 4 at 6:23 PMAfter revisions, Philadelphia-based Carisma Therapeutics poised to close merger with Sesen Biobizjournals.com - March 6 at 7:17 PMJefferies Financial Group Weighs in on Sesen Bio, Inc.'s FY2023 Earnings (NASDAQ:SESN)marketbeat.com - March 3 at 8:18 AMSesen Bio wins shareholder approval for Carisma mergermsn.com - March 2 at 1:30 PMSesen Bio Stockholders Approve Merger with Carisma Therapeuticsfinance.yahoo.com - March 2 at 1:30 PMSesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Resultsfinance.yahoo.com - February 28 at 12:42 PMSHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and SHBI Shareholders About Its Ongoing Investigationsbenzinga.com - February 24 at 9:19 PMLeading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote "FOR" All Proposals to Approve Pending Merger With Carismafinance.yahoo.com - February 21 at 10:50 AMBML, One of Sesen Bio's Top Stockholders, Announces Support for Pending Merger with Carisma Therapeuticsstockhouse.com - February 17 at 8:59 PMLeading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meetingbusinesswire.com - February 16 at 4:47 PMSesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Mergerfinance.yahoo.com - February 16 at 9:10 AM5 big dividend moves: Group 1 Automotive hikes by 20% | Pro Recapfinance.yahoo.com - February 15 at 9:11 AMBML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma Therapeuticsfinance.yahoo.com - February 15 at 9:11 AMSesen Bio, Carisma Therapeutics amend merger deal after reaching agreement with investor groupbizjournals.com - February 14 at 2:01 PMSesen gains 11% on amended terms for merger with Carismamsn.com - February 14 at 9:00 AMSesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Mergerfinance.yahoo.com - February 14 at 9:00 AMSesen Bio (NASDAQ:SESN) investors are sitting on a loss of 37% if they invested three years agofinance.yahoo.com - February 6 at 10:17 AMSesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Mergerfinance.yahoo.com - February 2 at 7:29 PMThe Petri Dish: Departed White House adviser returns to the Broadfinance.yahoo.com - February 2 at 9:28 AMSesen Bio Receives NASDAQ Delisting Noticefinance.yahoo.com - January 30 at 9:50 AMSesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholdersfinance.yahoo.com - January 26 at 9:50 AMSesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connection with Pending Merger with Carisma Therapeuticsfinance.yahoo.com - January 19 at 6:16 PMSHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigationsbenzinga.com - January 6 at 5:46 PMInvestor Group Issues Letter to Sesen Bio’s Board of Directors Regarding Intent to Vote AGAINST Proposed Carisma Mergerfinance.yahoo.com - January 5 at 10:16 AMSesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeuticsfinance.yahoo.com - January 4 at 1:26 PMSesen Bio investors reiterate plan to vote against Carisma mergermsn.com - January 3 at 8:04 PMCarisma Therapeutics and Sesen Bio merger draws opposition from large shareholderfinance.yahoo.com - January 3 at 3:02 PMInvestor Group Reiterates Intent to Vote AGAINST Sesen Bio's Value-Destructive Merger with Carismatechnews.tmcnet.com - January 3 at 10:02 AMInvestor Group Reiterates Intent to Vote AGAINST Sesen Bio’s Value-Destructive Merger with Carismafinance.yahoo.com - January 3 at 10:02 AMStocks to Watch: Sesen Bio, Model Performance Acquisition, Heidrick & Strugglesmarketwatch.com - December 31 at 6:04 PMWhy Sesen Bio Shares Are Skyrocketing Friday?benzinga.com - December 30 at 2:28 PMSHAREHOLDER ALERT: Weiss Law Reminds WEBR, SESN, MLVF, and VLON Shareholders About Its Ongoing Investigationsbenzinga.com - December 29 at 11:20 PMSESEN BIO, INC. (SESN) Upgraded to Buy: What Does It Mean for the Stock?finance.yahoo.com - November 30 at 4:19 PMBradley Louis Radoff Discloses Activist Position in SESN / Sesen Bio247wallst.com - November 22 at 5:37 AMSesen Bio, Inc. to Post Q4 2022 Earnings of ($0.11) Per Share, Jefferies Financial Group Forecasts (NASDAQ:SESN)marketbeat.com - November 13 at 3:03 AMSesen Bio: Q3 Earnings Insightsmsn.com - November 7 at 11:19 AMSesen Bio Reports Third Quarter 2022 Financial Results and Business Updatefinance.yahoo.com - November 7 at 11:19 AMSesen Bio (SESN) to Report Q3 Earnings: What's in the Cards?finance.yahoo.com - October 27 at 5:03 PMSESEN BIO, INC. (SESN) Flat As Market Gains: What You Should Knowfinance.yahoo.com - October 21 at 7:21 PMSESEN BIO, INC. (SESN) Gains As Market Dips: What You Should Knowmsn.com - October 14 at 7:18 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OCSL, SESN, ISRmarkets.businessinsider.com - October 11 at 2:40 PMSESEN BIO, INC. (SESN) Stock Moves -0.43%: What You Should Knowfinance.yahoo.com - September 30 at 12:13 AMThe Petri Dish: Embattled Sesen Bio shuts down via mergerfinance.yahoo.com - September 22 at 7:01 AMSesen Bio Shares Sink After Merger Newsmarketwatch.com - September 21 at 3:56 PMNovartis, Moderna Partner Agrees To Merge With Beleaguered Sesen Biofinance.yahoo.com - September 21 at 3:56 PMSesen Bio to Merge With Carisma Therapeuticsmarketwatch.com - September 21 at 10:25 AMSesen Bio, Carisma To Mergemarkets.businessinsider.com - September 21 at 10:25 AMSesen Bio in merger deal with immunotherapy company Carisma Therapeuticsseekingalpha.com - September 21 at 10:25 AMSesen Bio and Carisma Therapeutics Announce Merger Agreementfinance.yahoo.com - September 21 at 10:25 AM Get Sesen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for SESN and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden to Launch “FedNOW” [Move Your Money Now] (Ad)Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar... Get your free information kit NOW, before it's too late. SESN Media Mentions By Week SESN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SESN News Sentiment▼0.000.42▲Average Medical News Sentiment SESN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SESN Articles This Week▼00▲SESN Articles Average Week Get Sesen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for SESN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Indivior News Janux Therapeutics News Summit Therapeutics News Evotec News Rhythm Pharmaceuticals News MorphoSys News Merus News Corcept Therapeutics News ACADIA Pharmaceuticals News MoonLake Immunotherapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SESN) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sesen Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
